交易中 09-20 11:34:18 美东时间
-0.020
-3.02%
IceCure Medical (NASDAQ:ICCM) said an FDA advisory committee will meet on Nov. 7 to discuss its De Novo Classification Request for market authorization of its ProSense cryoablation device. The Israeli...
09-12 23:27
Icecure Medical (ICCM) has released an update. IceCure Medical Ltd. has been gr...
08-28 21:17
Maxim Group analyst Anthony Vendetti has reiterated their bullish stance on ICC...
08-22 03:55
Icecure Medical (ICCM) has released an update. Icecure Medical’s mid-year finan...
08-20 21:27
Icecure Medical (ICCM) has released an update. IceCure Medical Ltd., in a recen...
08-07 05:00
Icecure Medical (ICCM) has released an update. IceCure Medical recently announc...
07-22 21:27
IceCure Medical Ltd. (NASDAQ:ICCM) (the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that it has
07-20 04:31
Icecure Medical (ICCM) has released an update. IceCure Medical’s latest Europea...
07-09 21:17
Analyst Yi Chen from H.C. Wainwright reiterated a Buy rating on Icecure Medical...
07-02 18:15
Icecure Medical (ICCM) has released an update. IceCure Medical Ltd. has announc...
07-01 21:21